Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives

Despite the application of conventional therapies, the prognosis of advanced gastric cancer (GC) or gastroesophageal junction cancer (GEJC) is still poor. In recent years, immune checkpoint inhibitors (ICIs) have reshaped the paradigm of cancer therapy. Emerging evidence support the feasibility of p...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Chin J Cancer Res
Главные авторы: Zhang, Zhening, Xie, Tong, Zhang, Xiaotian, Qi, Changsong, Shen, Lin, Peng, Zhi
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2020
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369180/
https://ncbi.nlm.nih.gov/pubmed/32694895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2020.03.02
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы